Chase Coleman’s ResMed RMD Stock Holding History

Chase Coleman’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q4	–	Sell	-1,000,000	Closed	-$49.3M	–	64
2014 Q3	$49.3M	Hold	1,000,000	–	–	0.65%	29
2014 Q2	$50.6M	Hold	1,000,000	–	–	0.64%	30
2014 Q1	$44.7M	Hold	1,000,000	–	–	0.61%	29
2013 Q4	$47.1M	Buy	+1,000,000	New	+$50.6M	0.59%	33

Other funds holding RMD

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

CBOA

Commonwealth Bank of Australia Sydney, NSW, Australia $355M AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return

Chase Coleman's RMD Position: Q4 2014 in Review

Chase Coleman sold out of ResMed (RMD) in Q4 2014, closing a stake of 1,000,000 shares — an estimated $49.3M sold.

Chase Coleman first reported a position in RMD in Q4 2013 and held it in 4 quarters. The position peaked at $50.6M in Q2 2014. 309 funds tracked by Wall St. Rank hold RMD as of Q4 2014.

Chase Coleman reported no remaining ResMed position as of Q4 2014 after selling out during the quarter.
Chase Coleman sold 1,000,000 ResMed shares in Q4 2014, an estimated $49.3M.
Chase Coleman first reported a position in ResMed in Q4 2013 and held it in 4 quarters.
Chase Coleman's ResMed position peaked at $50.6M in Q2 2014.
309 funds tracked by Wall St. Rank held ResMed as of Q4 2014.

Based on Tiger Global Management's 13F filing for Q4 2014, filed 17 Feb 2015.